Successful treatment of Acrodermatitis continua of Hallopeau associated with psoriatic arthritis with adalimumab

Acrodermatitis continua of Hallopeau (ACH) is a rare form of pustular psoriasis, mainly affecting distal phalanges of hands and feet. Many therapeutic options exist; however, it tends to be resistant to treatment. We report a 26-year-old man presented with a very severe psoriatic arthritis associate...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of rheumatology Vol. 2; no. 2; pp. 78 - 79
Main Authors Lefkir, Salima, Slimani, Samy, Brahimi, Nadjia, Ladjouze-Rezig, Aicha
Format Journal Article
LanguageEnglish
Published Turkey Medical Research and Education Association 01.06.2015
Subjects
Case Report
Acrodermatitis continua of Hallopeau
adalimumab
psoriatic arthritis
Online AccessGet full text

Cover

More Information
Summary:Acrodermatitis continua of Hallopeau (ACH) is a rare form of pustular psoriasis, mainly affecting distal phalanges of hands and feet. Many therapeutic options exist; however, it tends to be resistant to treatment. We report a 26-year-old man presented with a very severe psoriatic arthritis associated with ACH. Although this patient was resistant to a first line treatment (glucocorticoids and methotrexate), a rapid and dramatic improvement was observed after adalimumab was introduced. The effectiveness and tolerance of the treatment were maintained during the 12-month period of follow-up. This is the first report of the efficacy of adalimumab on ACH in a patient presented with psoriatic arthropathy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2147-9720
2148-4279
DOI:10.5152/eurjrheum.2015.0072